LAGE-2A Activators
LAGE-2A Activators refer to a specialized group of compounds that are designed to interact with and upregulate the activity of the LAGE-2A protein. LAGE-2A, which stands for L Antigen Family Member 2A, is a protein that is understood to play a role in cellular processes, possibly including the regulation of gene expression or involvement in signaling pathways. The precise biological function of LAGE-2A is not fully elucidated, but it is hypothesized that it may have relevance to the normal functioning of certain cellular mechanisms. Activators in this chemical class are structured to bind to the LAGE-2A protein and induce a conformational change or alter its stability, thereby potentially affecting its interaction with other cellular components. The goal of these activators is to modulate the function of LAGE-2A, either by increasing its expression, enhancing its ability to interact with other proteins, or by influencing its activity within the cell.
The study and characterization of LAGE-2A Activators require the integration of various biochemical and molecular biology techniques. Initially, compound libraries may be screened using in vitro assays to identify molecules that can increase the activity or expression of LAGE-2A. Following the identification of potential activators, detailed analyses would be performed to understand the mechanism of action. This might involve utilizing techniques such as surface plasmon resonance or isothermal titration calorimetry to study the binding kinetics between LAGE-2A and the activators. Advanced proteomic approaches might also be employed to detect post-translational modifications of LAGE-2A that could be induced by these activators, providing insight into how these modifications affect the protein's function. Through these comprehensive studies, researchers aim to unravel the complexities of LAGE-2A's role within the cell and how it can be modulated by small molecules, contributing to the foundational knowledge of cellular biology and protein regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can demethylate DNA and potentially induce the expression of CTAG1A. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that can change chromatin structure to a more open state, potentially increasing CTAG1A expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, it can cause DNA demethylation and potentially increase the expression of genes like CTAG1A. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another HDAC inhibitor that may induce hyperacetylation of histones, potentially upregulating CTAG1A expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Can alter protein degradation and metal ion chelation, which might stress cells and induce CTAG1A expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As an HDAC inhibitor, it can lead to hyperacetylation of histones and potentially increase CTAG1A expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that may lead to chromatin remodeling and influence the expression of CTAG1A. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
An HDAC inhibitor that could change the transcriptional landscape of cancer cells, including CTAG1A expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
An HDAC inhibitor that might alter gene expression patterns, possibly affecting CTAG1A expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can cause cellular stress and might induce the expression of immunogenic antigens like CTAG1A. | ||||||